IRIS
GALEAZZI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.747
EU - Europa 24.958
AS - Asia 5.145
SA - Sud America 753
AF - Africa 132
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 27
AN - Antartide 1
Totale 60.799
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.636
GB - Regno Unito 9.074
IE - Irlanda 3.648
CN - Cina 3.151
UA - Ucraina 2.739
SE - Svezia 2.034
IT - Italia 1.799
RU - Federazione Russa 1.557
DE - Germania 1.526
SG - Singapore 1.480
FR - Francia 1.342
FI - Finlandia 706
BR - Brasile 666
ES - Italia 109
TR - Turchia 96
VN - Vietnam 95
BE - Belgio 92
NL - Olanda 82
CA - Canada 78
IN - India 64
CI - Costa d'Avorio 59
CZ - Repubblica Ceca 49
HK - Hong Kong 39
AU - Australia 30
PL - Polonia 30
AT - Austria 29
EU - Europa 25
MA - Marocco 22
GR - Grecia 21
IR - Iran 21
KR - Corea 21
AR - Argentina 15
BD - Bangladesh 14
BG - Bulgaria 14
CH - Svizzera 14
EC - Ecuador 14
MX - Messico 14
LT - Lituania 13
ZA - Sudafrica 13
EG - Egitto 12
JP - Giappone 12
PK - Pakistan 12
PY - Paraguay 12
DK - Danimarca 11
IL - Israele 11
IQ - Iraq 11
PE - Perù 11
VE - Venezuela 11
ID - Indonesia 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
CO - Colombia 9
RO - Romania 9
SA - Arabia Saudita 9
KE - Kenya 8
MY - Malesia 8
PT - Portogallo 8
TN - Tunisia 8
UZ - Uzbekistan 8
BO - Bolivia 7
KG - Kirghizistan 7
KZ - Kazakistan 7
PH - Filippine 7
SK - Slovacchia (Repubblica Slovacca) 7
CL - Cile 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
LV - Lettonia 6
NZ - Nuova Zelanda 6
AM - Armenia 5
HR - Croazia 5
JO - Giordania 5
LU - Lussemburgo 5
NP - Nepal 5
AL - Albania 4
DZ - Algeria 4
KH - Cambogia 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
LK - Sri Lanka 4
PA - Panama 4
CY - Cipro 3
IM - Isola di Man 3
MK - Macedonia 3
RS - Serbia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
CR - Costa Rica 2
CU - Cuba 2
EE - Estonia 2
ET - Etiopia 2
LB - Libano 2
NO - Norvegia 2
OM - Oman 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GL - Groenlandia 1
Totale 60.785
Salva come PNG Salva come JPEG
Città #
Southend 8.589
Fairfield 3.997
Dublin 3.609
Menlo Park 2.428
Chandler 2.262
Jacksonville 2.232
Ashburn 2.229
Woodbridge 1.904
Houston 1.847
Wilmington 1.543
Seattle 1.479
Cambridge 1.342
Santa Clara 1.260
Ann Arbor 1.163
Nanjing 757
Princeton 735
Beijing 664
Singapore 531
Siena 529
Boardman 336
San Mateo 316
New York 287
Helsinki 280
Nanchang 250
San Diego 248
Dearborn 180
Shenyang 175
Moscow 171
Düsseldorf 162
Council Bluffs 137
Hebei 127
Shanghai 127
Tianjin 124
Changsha 116
Venezia 107
Jiaxing 105
Málaga 96
Dong Ket 90
Kunming 88
Brussels 87
Lancaster 86
Milan 82
Jinan 74
Rome 74
São Paulo 69
Norwalk 66
Munich 64
Abidjan 59
Izmir 59
London 58
Los Angeles 56
Washington 56
Toronto 55
Saint Petersburg 53
Zhengzhou 52
Guangzhou 51
Mestre 50
Ningbo 49
San Francisco 47
Hangzhou 45
Falls Church 44
Redwood City 42
Changchun 41
Florence 38
Taizhou 35
Hong Kong 28
The Dalles 28
Brno 25
Hefei 25
Lanzhou 25
Tappahannock 25
Frankfurt am Main 24
Rio de Janeiro 24
Fremont 23
Bologna 22
Fuzhou 19
Belo Horizonte 18
Kraków 18
Nuremberg 18
Olomouc 18
Hounslow 17
Kiev 16
Vienna 15
Asciano 14
Padova 14
Paris 14
Amsterdam 13
Campinas 13
Chiswick 13
Pisa 13
Portsmouth 13
Chicago 12
Kilburn 12
Phoenix 12
Prescot 12
Edinburgh 11
Lauterbourg 11
Philadelphia 11
Sofia 11
Bari 10
Totale 44.711
Salva come PNG Salva come JPEG
Nome #
null 412
UNIREUMA -REUMATOLOGIA PER STUDENTI E MEDICI DI MEDICINA GENERALE I EDIZIONE 394
Comparison of combination therapies in the treatment of rheumatoid arthritis :leflunomide-anti-TNF-alfa versus methotrexate-anti-TNF-alfa 369
Livello sierico della COMP (Cartilage Oligomeric Matrix Protein): Uso potenziale come marker di progressione del danno articolare nei pazienti con "Early Rheumatoid Arthritis" 291
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 277
Obesity reduces the response rate to anti TNFα in rheumatoidarthritis. an approach to a personalized medicine 256
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 254
Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung 250
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 250
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 246
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry 245
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 243
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 234
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 229
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 228
Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature 223
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project" 222
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 221
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 221
Validation of an Italian version of the functional index for hand osteoarthritis (FIHOA) 219
Antiarrhythmic potential of anti-cytokine therapy in rheumatoid arthritis: Tocilizumab reduces QTc interval by controlling systemic inflammation. 219
Expression of RXFP1 in skin of scleroderma patients and control subjects 215
One-year follow-up of mud-bath therapy in patients with bilateral knee osteoarthritis: a randomized, single-blind controlled trial 215
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 214
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 214
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 213
Change perspective to increase diagnostic accuracy of ultrasonography in calcium pyrophosphate dehydrate deposition disease! A new approach: The axial scan of the meniscus 212
Bone mineral density in patients with systemic sclerosis. 211
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 209
Alkaptonuria is a novel human secondary amyloidogenic disease 207
Circulating levels of adiponectin, resistin, and visfatin after mud-bath therapy in patients with bilateral knee osteoarthritis 202
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 201
FRI0501 Ultrasound versus synovial fluid analysis for the diagnosis of calcium pyrophosphate dihydrate deposition disease: preliminary results 201
Ultrasonography and magnetic resonance imaging of heel fat pad inflammatory-oedematous lesions in rheumatoid arthritis 200
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 199
The Immunogenetics of the Antiphospholipid Syndrome, Anticardiolipin Antibodies, and Lupus Anticoagulant 198
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 198
Weekly oral alendronate in mevalonate kinase deficiency 195
Colchicine myopathy and neuromyopathy: two cases with different characteristics 195
Statins and the joint: multiple targets for a global protection? 195
High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus 194
Deltoideal acromial enthesopathy in ankylosing spondylitis and in spondylarthropathies: comment on the article by Lambert et al. 193
A "new" technique for the diagnosis of chondrocalcinosis of the knee: sensitivity and specificity of high-frequency ultrasonography 193
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes 193
SAT0312 Ultrasound Reliability in the Diagnosis of Calcium Pyrophosphate Deposition Disease: Agreement Between Observers and Main Causes of Discordance 192
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 192
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 191
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 189
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 189
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations 188
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 188
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection 187
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 186
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus 184
AB0969 Accuracy of blind intra-articular injections in patients with osteoarthritis of the knee. An ultrasonography controlled study 184
Increased serum leptin and visfatin levels in patients with diffuse idiopathic skeletal hyperostosis: a comparative study 183
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 183
Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis 182
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 182
Could oxidative stress regulate the expression of microRNA-146a and microRNA-34a in human osteoarthritic chondrocyte cultures? 180
FRI0533 Ultrasonographic Features of Joints and Entheses in Healty Children 179
AB1308 Prevalence of baker’s CYST in patients with chronic gonalgia and relationship with major non inflammatory diseases 179
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 179
Granulomatosis with polyangiitis and intravenous immunoglobulins: A case series and review of the literature 178
SAT0542 The Prevalence of Calcium Pyrophosphate Deposits at Ultrasound Examination: Retrospective Analysis in A Cohort of Patients 177
SAT0530 The Useful of us in Diagnosis of Carpal Tunnel Syndrome in Diabetics: a Proposal for New Reference Values 177
Hydrostatic pressure regulates MicroRNA expression levels in osteoarthritic chondrocyte cultures via the Wnt/β-catenin pathway 177
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients 176
AB0535 Effects of tocilizumab on bone density and metabolism in patients with active rheumatoid arthritis 176
Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series 176
SAT0315 Calcium Pyrophosphate Dihydrate Deposition Disease: A Proposal of New Ultrasonographic Criteria for CPP Identification in the Joints 176
Working the endless puzzle of hereditary autoinflammatory disorders. 175
Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection 175
High frequency of psoriasis in relatives is associated with early onset in an Italian multiple sclerosis cohort 175
Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis 173
Can hybrid hyaluronic acid represent a valid approach to treat rizoarthrosis? A retrospective comparative study 173
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 173
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 172
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 172
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 171
Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed. 170
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 170
Fasitibant prevents the bradykinin andinterleukin 1β synergism on prostaglandin E(2) release and cyclooxygenase 2expression in human fibroblast-like synoviocytes 170
Untangling the Web of Systemic Autoinflammatory Diseases 169
Sindrome di Churg-Strauss e gravidanza efficacia del trattamento con immunoglobuline endovena 169
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 169
Relationship between serum comp levels and serological markers of disease activity in rheumatoid arthritis patients treated with anti-tnf drugs. A study of the best way to manage indicators of response to therapy 169
SAT0510 Ultrasound versus Synovial Fluid Analysis for the Diagnosis of Calcium Pyrophosphate Dihydrate Deposition Disease: is IT Cppd? Ask Us! 168
Autoinflammatory disorders and patients with isolated serosal involvement. 167
A whitish-creamysynovial fluid. 167
Very low prevalence of anti-CCP antibodies in rheumatoid factor-negative psoriatic polyarthritis 167
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 166
Connective tissue diseases and cardiac rhythm disorders: an overview 165
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 164
Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease 163
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 162
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 162
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis 161
Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments 161
Short- and long-term effects of spa therapy in knee osteoarthritis 160
Totale 19.978
Salva come PNG Salva come JPEG
Categoria #
all - tutte 190.723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 190.723
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.307 0 0 0 0 0 0 0 0 0 1.124 448 735
2020/20217.859 397 940 195 776 357 1.120 274 1.245 734 588 634 599
2021/20226.301 532 768 428 492 430 157 258 244 441 737 589 1.225
2022/20238.041 535 580 1.077 1.189 872 1.655 108 630 835 164 256 140
2023/20245.287 232 130 441 299 188 1.553 1.757 142 24 61 71 389
2024/20256.153 229 609 859 616 1.286 530 250 617 845 312 0 0
Totale 61.363